• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 6
  3. Author

Online ISSN: 2515-8260

Volume9, Issue6

Study of empyema and intrapleural streptokinase in management of paediatric empyema in resource limited settings

    Dr. Sudhir D, Dr. K Nagaraj

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 6, Pages 2179-2187

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

 
In empyema, white blood cells migrate to infected pleural space causing release of fibrinogen and its conversion to fibrin, which causes tissue surfaces to adhere and this will trap micro-organisms and prevent host defence mechanisms and antibiotics from reaching the site of infection. ICTD with antibiotics remains the cornerstone in management of pediatric empyema. But ICTD is hampered by presence of either thick pus which tends to block tube or fibrin deposition causing multiple loculations that cannot be drained by single chest tube. Decision for insertion of ICD was taken depending upon clinical condition of the patient, radiological and laboratory evidence. Single dose of Inj. Streptokinase, 15,000 IU/kg body wt. was dissolved in 100ml normal saline and instilled in pleural cavity through ICD over a period of 1 hour and tube was clamped for 4 hours. Patient was asked to frequently change position, so that Streptokinase could thoroughly spread in pleural cavity. 25/27 (92.5%) in ICD group had good lung expansion on follow-up. Two had persistent collapse who improved further on physiotherapy. All patients in ICD with SK group had good lung expansion.
 
Keywords:
  • PDF (210 K)
  • XML
(2022). Study of empyema and intrapleural streptokinase in management of paediatric empyema in resource limited settings. European Journal of Molecular & Clinical Medicine, 9(6), 2179-2187.
Dr. Sudhir D, Dr. K Nagaraj. "Study of empyema and intrapleural streptokinase in management of paediatric empyema in resource limited settings". European Journal of Molecular & Clinical Medicine, 9, 6, 2022, 2179-2187.
(2022). 'Study of empyema and intrapleural streptokinase in management of paediatric empyema in resource limited settings', European Journal of Molecular & Clinical Medicine, 9(6), pp. 2179-2187.
Study of empyema and intrapleural streptokinase in management of paediatric empyema in resource limited settings. European Journal of Molecular & Clinical Medicine, 2022; 9(6): 2179-2187.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 11
  • PDF Download: 59
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus